Unknown PHASE4 INTERVENTIONAL 2-arm NCT01346007

Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome

Study of Safety, Immunogenicity and Immunological Memory of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome

Sponsor: National and Kapodistrian University of Athens

Conditions Idiopathic Nephrotic Syndrome

Interventions 7-valent pneumococcal conjugate vaccine

Updated 5 times since 2017 Last updated: Apr 29, 2011 Started: Jan 31, 2009 Primary completion: Jun 30, 2010 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Idiopathic Nephrotic Syndrome and is currently ongoing. National and Kapodistrian University of Athens leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National and Kapodistrian University of Athens

Data source: National and Kapodistrian University of Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Goudi, Greece